Form D · Other Health Care
Aruene Corp
Baltimore, MD · CIK 0001929244
Offering snapshot reported Jul 13, 2023 · SEC filing
- Reported sold
- $3.08M Offering amount: $5M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2023 | Initial | $3,080,000 | No comparison | 20 | SEC filing |
| May 18, 2022 | Initial | $2,931,011 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486763
Source: Form D, filed Jul 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Knox | Director |
| David Rosen | Director, Executive |
| Spencer Segura | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
101 W. Dickman St. Suite 900
Baltimore, MD, 21230
Baltimore, MD, 21230